34.95
1.83%
-0.65
Handel nachbörslich:
34.95
Finanzdaten der Kymera Therapeutics Inc-Aktie (KYMR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
912.80%
47.88
|
4.728 | 16.51 | 9.466 | 16.14 |
Operating Expenses
|
7.97%
67.20
|
62.24 | 59.90 | 54.79 | 54.77 |
Benefits Costs and Expenses |
225.55
|
- | - | 50.39 | 51.00 |
Costs And Expenses |
21.86%
48.63
|
62.24 | 59.90 | 50.39 | 51.00 |
Operating Income/Loss |
66.42%
-19.31
|
-57.51 | -43.38 | -45.33 | -38.63 |
Income/Loss From Continuing Operations Before Tax |
3,858%
-177.67
|
4.728 | 16.51 | -40.93 | -34.87 |
Income/Loss From Continuing Operations After Tax |
72.82%
-14.37
|
-52.87 | -38.80 | -40.93 | -34.87 |
Net Income/Loss
|
72.82%
-14.37
|
-52.87 | -38.80 | -40.93 | -34.87 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.91%
0.0527
|
58.42 | 58.33 | 58.19 | 1.3331 |
Diluted Average Shares |
99.91%
0.0527
|
58.42 | 58.33 | 58.19 | 1.3331 |
Basic Earnings Per Share |
72.22%
-0.25
|
-0.90 | -0.67 | -0.70 | -0.59 |
Diluted Earnings Per Share |
72.22%
-0.25
|
-0.90 | -0.67 | -0.70 | -0.59 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):